Barinthus Biotherapeutics plc (BRNS)
USD 1.04
(6.23%)
USD 1.04
(6.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 802 Thousand | 44.7 Million | 268 Thousand | 4.82 Million | 6.87 Million |
| Cost of Revenue | - | - | - | - | -0.55 |
| Gross Profit | 802 Thousand | 44.7 Million | 268 Thousand | 4.82 Million | 6.87 Million |
| Operating Expenses | 84.71 Million | 47.5 Million | 41.48 Million | 21.58 Million | 32.29 Million |
| Selling, General and Administrative Expenses | 39.84 Million | 6.39 Million | 25.11 Million | 10.48 Million | 2.33 Million |
| Research and Development Expenses | 44.87 Million | 41.11 Million | 16.37 Million | 11.1 Million | 29.96 Million |
| Other Expenses | - | 567 Thousand | 332 Thousand | 42 Thousand | - |
| Cost and Expenses | 84.71 Million | 47.5 Million | 41.48 Million | 21.58 Million | 32.64 Million |
| Operating Income | -83.91 Million | -4.04 Million | -45.22 Million | -20.04 Million | -25.77 Million |
| Interest Expense | 28 Thousand | 19 Thousand | 2.66 Million | 3.6 Million | 133.29 Thousand |
| Income Tax Expense | -3.17 Million | -4.47 Million | -28 Thousand | 95 Thousand | -2.01 Million |
| Earnings before Tax | -76.52 Million | 850 Thousand | -51.14 Million | -17.83 Million | -22.79 Million |
| Net Income | -73.34 Million | 5.34 Million | -50.86 Million | -17.7 Million | -20.81 Million |
| Earnings Per Share Basic | -1.91 | 0.14 | -1.37 | -371.62 | - |
| Earnings Per Share Diluted | -1.91 | 0.14 | -1.37 | -371.62 | - |
| Weighted Average Shares Outstanding | 38.38 Million | 37.24 Million | 37.18 Million | 47.64 Thousand | - |
| Weighted Average Shares Outstanding (Diluted) | 38.38 Million | 38.16 Million | 37.18 Million | 47.64 Thousand | - |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -93.29 | 0.12 | -150.31 | -3.43 | -3.70 |
| Profit Margin | -91.46 | 0.12 | -189.79 | -3.67 | -3.03 |
| EBITDA | -74.81 Million | 6.4 Million | -47.86 Million | -14.13 Million | -22.31 Million |
| Earnings Before Tax Margin | -104.63 | -0.09 | -168.74 | -4.16 | -3.75 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 5.36 Million | 805.1 Thousand | - | 334 Thousand |
| Cost of Revenue | 1.46 Million | 1.42 Million | 1.44 Million | 3108.00 | 1.46 Million | 1.62 Million |
| Gross Profit | -1.46 Million | -1.42 Million | 3.92 Million | 802 Thousand | -1.46 Million | -1.28 Million |
| Operating Expenses | 17.51 Million | 15.68 Million | 23.1 Million | 85.04 Million | 14.9 Million | 26.11 Million |
| Selling, General and Administrative Expenses | 5.84 Million | 4.56 Million | 13.73 Million | - | 961 Thousand | 13.12 Million |
| Research and Development Expenses | 11.67 Million | 11.11 Million | 9.37 Million | - | 13.93 Million | 12.98 Million |
| Other Expenses | 20 Thousand | - | 774 Thousand | 1.08 Million | -2000.00 | 310 Thousand |
| Cost and Expenses | 18.98 Million | 17.1 Million | 23.1 Million | 85.04 Million | 14.9 Million | 26.11 Million |
| Operating Income | -18.98 Million | -17.1 Million | -23.1 Million | -84.23 Million | -16.1 Million | -26.33 Million |
| Interest Expense | 12 Thousand | 12 Thousand | 7060.89 | 28.1 Thousand | 7000.00 | 14 Thousand |
| Income Tax Expense | -700.78 Thousand | -630.63 Thousand | -827.13 Thousand | -3.08 Million | -603 Thousand | -1.13 Million |
| Earnings before Tax | -17.66 Million | -16.14 Million | -18.26 Million | -76.81 Million | -14.71 Million | -24.96 Million |
| Net Income | -16.94 Million | -15.48 Million | -17.44 Million | -73.63 Million | -14.07 Million | -23.8 Million |
| Earnings Per Share Basic | -0.43 | -0.40 | -0.45 | - | -0.37 | -0.62 |
| Earnings Per Share Diluted | -0.43 | -0.40 | -0.45 | - | -0.37 | -0.62 |
| Weighted Average Shares Outstanding | 39.04 Million | 38.77 Million | 38.6 Million | 38.38 Million | 38.53 Million | 38.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.04 Million | 38.77 Million | 38.6 Million | 38.38 Million | 38.53 Million | 38.4 Million |
| Gross Margin | - | - | 0.73 | 1.00 | - | -3.85 |
| EBIT Margin | - | - | -3.10 | - | - | -70.80 |
| Profit Margin | - | - | -3.25 | -91.46 | - | -71.26 |
| EBITDA | -17.51 Million | -15.68 Million | -16.66 Million | - | -13.23 Million | -23.64 Million |
| Earnings Before Tax Margin | - | - | -4.30 | -104.63 | - | -78.85 |
FUNC
ORN
GGPXF
6668
9888
IPW